JPMorgan Lands Back-to-Back Trillion-Dollar IPO Roles — and CEO Jamie Dimon Is Personally Selling Both Deals

JPMorgan Chase (JPM) has secured the lead role managing U.S. retail share sales for Anthropic's (ANT) upcoming initial public offering, reprising the exact function it performed during SpaceX's record-breaking $86.2 billion IPO in June and cementing a commanding lock on the retail distribution segment of mega-offerings. 

The dual mandate on what are shaping up to be the two largest IPOs of 2026 is notable not just for the fees involved — estimated at roughly $84 million in direct underwriting revenue on Anthropic alone — but because CEO Jamie Dimon is personally expected to help market both deals, a level of executive involvement that underscores how aggressively the bank is defending a competitive moat rivals will struggle to replicate.

Dimon's Star Turn as IPO Salesman

During the SpaceX (SPCX) listing, Dimon conducted a live Q&A session with Elon Musk that helped generate over $100 billion in individual investor demand — a staggering figure that effectively proved the viability of mass-scale retail allocations in trillion-dollar offerings. 

Anthropic is considering a retail allocation of approximately 15% to 20% of total shares on offer, with JPMorgan expected to coordinate outreach to high-net-worth individuals, private banking clients, and broker platforms.

The $562 Million Fee Pool

Analyst estimates suggest the Anthropic IPO could generate a total equity capital markets fee pool of roughly $562 million, with JPMorgan's $84 million share capturing only the direct underwriting component — not the ancillary revenue from wealth management relationships and trading commissions tied to the retail tranche. 

Goldman Sachs (GS) and Morgan Stanley (MS) hold the lead-left and lead-right underwriting positions on both deals, respectively, yet JPMorgan's retail distribution franchise arguably touches more individual investors than either bookrunner.

Citigroup (C) has been tapped to coordinate the international retail offering across markets including Australia, Canada, Japan, the U.K., Switzerland, and select European Economic Area countries.

A Valuation That Could Reach $2 Trillion

Investors have signaled a fair valuation range of $1.4 trillion to $1.75 trillion for Anthropic, with aspirations reaching as high as $2 trillion. That range would make the absolute dollar volume flowing through JPMorgan's retail channel enormous by any historical standard. 

The sheer scale dwarfs the broader 2026 IPO market, which has already raised $148 billion this year, more than seven times the prior-year pace.

The Musk-Shaped Hole in the Pitch

The Anthropic deal does present distinct marketing challenges compared to SpaceX, because CEO Dario Amodei — while respected in the AI research community — lacks the cultural magnetism of Elon Musk and does not generate the same retail investor fervor. 

That reality is expected to shift JPMorgan's strategy toward leveraging Dimon's own stature and credibility with ultra-high-net-worth clients rather than relying on founder celebrity appeal. 

What Comes Next for JPM

The fee windfall arrives at a favorable moment for JPMorgan's fourth-quarter earnings, layering on top of an already surging IPO market in 2026. 

From a strategic perspective, JPMorgan's back-to-back roles signal the firm has built a formidable institutional capability in distributing trillion-dollar IPOs to retail and private wealth channels — a moat that will be difficult for rivals to replicate in subsequent mega-listings. 

Dimon's visible engagement on these marquee transactions further undercuts speculation about an imminent retirement, reinforcing his positioning as arguably the most consequential Wall Street CEO of this era — and, apparently, its most effective IPO pitchman.

This article was created with the support of automated content tools from our partners at Sigma.AI. Together, our financial data and AI solutions help us to deliver more informed market headline analysis to readers faster than ever.  

On the date of publication, Sarah Holzmann did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.